Geke Hospers

Has grant

Professor of Medical Oncology

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Geke Hospers is a Professor of Medical Oncology at the University Medical Center Groningen in the Netherlands. His research primarily focuses on treatment outcomes in esophageal cancer and advanced melanoma, including studies on chemoradiotherapy regimens and immune-related adverse events. Recent publications highlight the impact of optimal staging in melanoma and the efficacy of various treatment approaches for advanced disease. Professor Hospers is dedicated to advancing the understanding and management of complex oncological conditions.

Recent Grants

Grant: Close

Microbiome Research

Open Date:

Close Date:

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Michel Wouters

Professor Quality of Cancer Care

Leiden University Medical Center

NETHERLANDS

View details

Elma Meershoek-Klein Kranenbarg

Head Clinical Research Center

Leiden University Medical Center

NETHERLANDS

View details

Jos van der Hage

Professor of Surgery

Leiden University Medical Center

NETHERLANDS

View details

Hein Putter

Professor

Leiden University Medical Center

NETHERLANDS

View details

Marco Donia

Copenhagen University Hospital

DENMARK

View details

Ellen H. W. Kapiteijn

Leiden University Medical Center

NETHERLANDS

View details

Karijn P. M. Suijkerbuijk

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Geke Hospers

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Impact of extending the original criteria in the Chemoradiotherapy for Oesophageal Cancer followed by Surgery Study (CROSS) regimen on treatment outcome in locally advanced esophageal cancer patients

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials

ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry

Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

Authors’ reply - A sensitivity analysis of the RAPIDO clinical trial

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors

Collaborators (7)

Michel Wouters

Elma Meershoek-Klein Kranenbarg

Jos van der Hage

Hein Putter

Marco Donia

Ellen H. W. Kapiteijn

Karijn P. M. Suijkerbuijk

Make your next move.